Shire says ADHD drug meets main goal of study

(Reuters) – Irish drugmaker Shire Plc said a study testing an experimental drug to treat attention-deficit disorder met the main goal, bringing the drug one step closer to approval in the United States.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *